Current literature in diabetes
John Wiley & Sons, Ltd.
Search for more papers by this authorJohn Wiley & Sons, Ltd.
Search for more papers by this authorAbstract
In order to keep subscribers up-to-date with the latest developments in their field, John Wiley & Sons are providing a current awareness service in each issue of the journal. The bibliography contains newly published material in the field of diabetes/metabolism. Each bibliography is divided into 26 sections: 1 Reviews; 2 General; 3 Genetics; 4 Epidemiology; 5 Immunology; 6 Obesity; 7 Prediction and Prevention; 8 Intervention: a) General; b) Care; c) Drug Therapy; d)Economics; e) Gene therapy; f) Nursing; g) Nutrition; h) Surgery; i) Transplantation; 9 Pathology and Complications: a) General; b) Cardiovascular; c) Eye disease; d) Gestational and fetal; e) Neurological; f) Podiatrical; g) Renal; 10 Endocrinology & Metabolism; 11 Experimental Studies; 12 Diagnosis and Techniques. Within each section, articles are listed in alphabetical order with respect to author
Current Awareness
- 1. Reviews
- American Diabetes Association. Nutrition recommendations and interventions for diabetes-2006 - A position statement of the American Diabetes Association. Diabetes Care (2006) 29: 2140
- Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA. Diabetic retinopathy - Seeing beyond glucose-induced microvascular disease. Diabetes (2006) 55: 2401
- Barnett AH, Dixon AN, Bellary S, Hanif MW. Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia (2006) 49: 2234
- Cherrington AD. 2005 presidential address: Diabetes: Past, present, and future. Diabetes Care (2006) 29: 2158
- Eves ND, Plotnikoff RC. Resistance training and type 2 diabetes: Considerations for implementation at the population level. Diabetes Care (2006) 29: 1933
- Garber AJ. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycemic control: A call to action. Diabetes Care (2006) 29: 1955
- Murphy HR, Rayman G, Skinner TC. Psycho-educational interventions for children and young people with type 1 diabetes. Diabet Med (2006) 23: 935
10.1111/j.1464-5491.2006.01816.x Google Scholar
- Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care (2006) 29: 1963
- Salpeter SR, Walsh JME, Ormiston TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: Effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab (2006) 8: 538
- Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: A meta-analysis of randomized double-blind controlled trials. Diabet Med (2006) 23: 1050
- Stork ADM, Van Haeften TW, Veneman TF. Diabetes and driving: Desired data, research methods and their pitfalls, current knowledge, and future research. Diabetes Care (2006) 29: 1942
- 3. Genetics
- Acton RT, Barton JC, Passmore LV, Adams PC, Speechley MR, Dawkins FW, Sholinsky P, Reboussin DM, McLaren GD, Harris EL, Bent TC, Vogt TM, Castro O. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the hemochromatosis and iron overload screening (HEIRS) study. Diabetes Care (2006) 29: 2084
- Avery CL, Freedman BI, Kraja AT, Borecki IB, Miller MB, Pankow JS, Arnett D, Lewis CE, Myers RH, Hunt SC, North KE. Genotype-by-sex interaction in the aetiology of type 2 diabetes mellitus: Support for sex-specific quantitative trait loci in Hypertension Genetic Epidemiology Network participants. Diabetologia (2006) 49: 2329
- Bonnycastle LL, Willer CJ, Conneely KN, Jackson AU, Burrill CP, Watanabe RM, Chines PS, Narisu N, Scott LJ, Enloe ST, Swift AJ, Duren WL, Stringham HM, Erdos MR, Riebow NL, Buchanan TA, Valle TT, Tuomilehto J, Bergman RN, Mohlke KL, Boehnke M, Collins FS. Common variants in maturity-onset diabetes of the young genes contribute to risk of type 2 diabetes in Finns. Diabetes (2006) 55: 2534
- Cohen RM, Snieder H, Lindsell CJ, Beyan H, Hawa MI, Blinko S, Edwards R, Spector TD, Leslie RDG. Evidence for independent heritability of the glycation gap, (glycosylation gap) fraction of HbA(1c) in nondiabetic twins. Diabetes Care (2006) 29: 1739
- Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen HQ, Silver KD, Mitchell BD, Shuldiner AR. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish - Replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes (2006) 55: 2654
- Das SK, Chu WS, Hale TC, Wang XQ, Craig RL, Wang H, Shuldiner AR, Froguel P, Deloukas P, McCarthy MI, Zeggini E, Hasstedt SJ, Elbein SC. Polymorphisms in the glucokinase-associated, dual-specificity phosphatase 12 (DUSP12) gene under chromosome 1q21 linkage peak are associated with type 2 diabetes. Diabetes (2006) 55: 2631
- Gloyn AL, Mackay DSG, Weedon MN, McCarthy MI, Walker M, Hitman G, Knight BA, Owen KR, Hattersley AT, Frayling TM. Assessment of the role of common genetic variation in the transient neonatal diabetes mellitus (TNDM) region in type 2 diabetes - A comparative genomic and tagging single nucleotide polymorphism approach. Diabetes (2006) 55: 2272
- Grarup N, Urhammer SA, Ek J, Albrechtsen A, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia (2006) 49: 2097
- Groves CJ, Zeggini E, Minton J, Frayling TM, Weedon MN, Rayner NW, Hitman GA, Walker M, Wiltshire S, Hattersley AT, McCarthy MI. Association analysis of 6,736 UK subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes (2006) 55: 2640
- Jian WX, Luo TH, Gu YY, Zhang HL, Zheng S, Dai M, Han JF, Zhao Y, Li G, Luo M. The visfatin gene is associated with glucose and lipid metabolism in a Chinese population. Diabet Med (2006) 23: 967
- Kang ES, Nam M, Kim HJ, Kim HJ, Myoung SM, Rhee Y, Ahn CW, Cha BS, Lee HC. Haplotype combination of calpain-10 gene polymorphism is associated with metabolic syndrome in type 2 diabetes. Diabetes Res Clin Pract (2006) 73: 268
- Lim SC, Goh SK, Lai YR, Tee WW, Koh A, Xu XH, Wu YS, Subramaniam T, Sum CF. Relationship between common functional polymorphisms of the p22phox gene (-930A > G and +242C > T) and nephropathy as a result of type 2 diabetes in a Chinese population. Diabet Med (2006) 23: 1037
- Liu W, Liu M, Fan WQ, Nawata H, Yanase T. The Gly146A1a variation in human SF-1 gene: Its association with insulin resistance and type 2 diabetes in Chinese. Diabetes Res Clin Pract (2006) 73: 322
- Luco RF, Maestro MA, Del Pozo N, Philbrick WM, De la Ossa PP, Ferrer J. A conditional model reveals that induction of hepatocyte nuclear factor-1α in Hnf1α-null mutant beta-cells can activate silenced genes postnatally, whereas overexpression is deleterious. Diabetes (2006) 55: 2202
- Ma J, Mollsten A, Prazny M, Falhammar H, Brismar K, Dahlquist G, Efendic S, Gu HF. Genetic influences of the intercellular adhesion molecule 1 (ICAM-1) gene polymorphisms in development of type 1 diabetes and diabetic nephropathy. Diabet Med (2006) 23: 1093
- Ng DPK, Placha G, Choo S, Chia KS, Warram JH, Krolewski AS. A disease haplotype for advanced nephropathy in type 2 diabetes at the ACE locus. Diabetes (2006) 55: 2660
- Richardson DK, Schneider J, Fourcaudot MJ, Rodriguez LM, Arya R, Dyer TD, Almasy L, Blangero J, Stern MP, DeFronzo RA, Duggirala R, Jenkinson CP. Association between variants in the genes for adiponectin and its receptors with insulin resistance syndrome (IRS)-related phenotypes in Mexican Americans. Diabetologia (2006) 49: 2317
- Rietveld I, Ikram MK, Vingerling JR, Hofman A, Pols HAP, Lamberts SWJ, De Jong PTVM, Van Duijn CM, Janssen JAMJL. An IGF-I gene polymorphism modifies the risk of diabetic retinopathy. Diabetes (2006) 55: 2387
- Scott LJ, Bonnycastle LL, Willer CJ, Sprau AG, Jackson AU, Narisu N, Duren WL, Chines PS, Stringham HM, Erdos MR, Valle TT, Tuomilehto J, Bergman RN, Mohlke KL, Collins FS, Boehnke M. Association of transcription factor 7-like 2 (TCF7L2) variants with type 2 diabetes in a Finnish sample. Diabetes (2006) 55: 2649
- Stene LC, Thorsby PM, Berg JP, Ronningen KS, Undlien DE, Joner G. The relation between size at birth and risk of type 1 diabetes is not influenced by adjustment for the insulin gene (-23HphI) polymorphism or HLA-DQ genotype. Diabetologia (2006) 49: 2068
- Sun L, Yang Z, Jin F, Zhu XQ, Qu YC, Shi XH, Wang L. The Gly482Ser variant of the PPARGC1 gene is associated with type 2 diabetes mellitus in northern Chinese, especially men. Diabet Med (2006) 23: 1085
- Talmud PJ, Cooper JA, Hattori H, Miller IP, Miller GJ, Humphries SE. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: Prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia (2006) 49: 2337
- Thamotharampillai K, Cusumano J, Chan AKF, Silink M, Bennetts B, Oates PJ, Craig ME, Donaghue KC. Decline in neurophysiological function after 7 years in an adolescent diabetic cohort and the role of aldose reductase gene polymorphisms. Diabetes Care (2006) 29: 2053
- Wegner L, Andersen G, Albrechtsen A, Sparso T, Glumer C, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. Large-scale study of the -232C > G polymorphism of PCK1 in type 2 diabetes. Diabet Med (2006) 23: 1140
- Yokoi N, Kanamori M, Horikawa Y, Takeda J, Sanke T, Furuta H, Nanjo K, Mori H, Kasuga M, Hara K, Kadowaki T, Tanizawa Y, Oka Y, Iwami Y, Ohgawara H, Yamada Y, Seino Y, Yano H, Cox NJ, Seino S. Association studies of variants in the genes involved in pancreatic beta-cell function in type 2 diabetes in Japanese subjects. Diabetes (2006) 55: 2379
- Zeggini E, Damcott CM, Hanson RL, Karim MA, Rayner NW, Groves CJ, Baier LJ, Hale TC, Hattersley AT, Hitman GA, Hunt SE, Knowler WC, Mitchell BD, Ng MC, O'Connell JR, Pollin TI, Vaxillaire M, Walker M, Wang X, Whittaker P, Xiang K, Jia W, Chan JC, Froguel P, Deloukas P, Shuldiner AR, Elbein SC, McCarthy MI. Variation within the gene encoding the upstream stimulatory factor 1 does not influence susceptibility to type 2 diabetes in samples from populations with replicated evidence of linkage to chromosome 1q. Diabetes (2006) 55: 2541
- Zhang CL, Qi L, Hunter DJ, Meigs JB, Manson JE, Van Dam RM, Hu FB. Variant of transcription factor 7-like 2 (TCF7L2) gene and the risk of type 2 diabetes in large cohorts of US women and men. Diabetes (2006) 55: 2645
- 4. Epidemiology
- Cardwell CR, Carson DJ, Patterson CC. Higher incidence of childhood-onset type 1 diabetes mellitus in remote areas: A UK regional small-area analysis. Diabetologia (2006) 49: 2074
- De Rekeneire N, Peila R, Ding J, Colbert LH, Visser M, Shorr RI, Kritchevsky SB, Kuller LH, Strotmeyer ES, Schwartz AV, Vellas B, Harris TB. Diabetes, hyperglycemia, and inflammation in older individuals - The health, aging and body composition study. Diabetes Care (2006) 29: 1902
- De Rooij SR, Painter RC, Phillips DIW, Osmond C, Michels RPJ, Godsland IF, Bossuyt PMM, Bleker OP, Roseboom TJ. Impaired insulin secretion after prenatal exposure to the Dutch famine. Diabetes Care (2006) 29: 1897
- Diamantopoulos EJ, Andreadis EA, Tsourous GI, Ifanti GK, Katsanou PM, Georgiopoulos DX, Vassilopoulos CV, Dimitriadis G, Raptis SA. Metabolic syndrome and prediabetes identify overlapping but not identical populations. Exp Clin Endocrinol Diabetes (2006) 114: 377
- Fan T, Koro CE, Fedder DO, Bowlin SJ. Ethnic disparities and trends in glycemic control among adults with type 2 diabetes in the US from 1988 to 2002. Diabetes Care (2006) 29: 1924
- Figaro MK, Kritchevsky SB, Resnick HE, Shorr RI, Butler J, Shintani A, Penninx BW, Simonsick EM, Goodpaster BH, Newman AB, Schwartz AV, Harris TB. Diabetes, inflammation, and functional decline in older adults: Findings from the health, aging and body composition (ABC) study. Diabetes Care (2006) 29: 2039
- Ginde AA, Pelletier AJ, Camargo CA. National study of US emergency department visits with diabetic ketoacidosis, 1993-2003. Diabetes Care (2006) 29: 2117
- Gulliford MC, Charlton J, Latinovic R, Hughes RAC. Increased incidence of carpal tunnel syndrome up to 10 years before diagnosis of diabetes. Diabetes Care (2006) 29: 1929
- Hunt KJ, Hansis-Diarte A, Shipman K, Korte JE, Fowler SP, Stern MP. Impact of parental smoking on diabetes, hypertension and the metabolic syndrome in adult men and women in the San Antonio Heart Study. Diabetologia (2006) 49: 2291
- Kirk JK, D'Agostino RB, Bell RA, Passmore LV, Bonds DE, Karter AJ, Narayan KMV. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: A meta-analysis. Diabetes Care (2006) 29: 2130
- Platat C, Wagner A, Klumpp T, Schweitzer B, Simon C. Relationships of physical activity with metabolic syndrome features and low-grade inflammation in adolescents. Diabetologia (2006) 49: 2078
- Schulz LO, Bennett PH, Ravussin E, Kidd JR, Kidd KK, Esparza J, Valencia ME. Effects of traditional and Western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the US. Diabetes Care (2006) 29: 1866
- Shi ZM, Hu XS, Yuan BJ, Pan XQ, Meyer HE, Holmboe-Ottesen G. Association between serum ferritin, hemoglobin, iron intake, and diabetes in adults in Jiangsu, China. Diabetes Care (2006) 29: 1878
- Shrestha UK, Singh DL, Bhattarai MD. The prevalence of hypertension and diabetes defined by fasting and 2-h plasma glucose criteria in urban Nepal. Diabet Med (2006) 23: 1130
- So WY, Kong APS, Ma RCW, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CWK, Chow CC, Cockram CS, Chan JCN, Tong PC. Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care (2006) 29: 2046
- Tarnow L, Gall MA, Hansen BV, Parving HH. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes. Diabetologia (2006) 49: 2256
- Vendramini MF, Ferreira SRG, Gimeno SGA, Kasamatsu TS, Miranda WL, Moises RS. Plasma adiponectin levels and incident glucose intolerance in Japanese-Brazilians: A seven-year follow-up study. Diabetes Res Clin Pract (2006) 73: 304
- Wang J, Williams DE, Narayan KMV, Geiss LS. Declining death rates from hyperglycemic crisis among adults with diabetes, US, 1985-2002. Diabetes Care (2006) 29: 2018
- 5. Immunology
- Fernandez-Real JM, Straczkowski M, Vendrell J, Soriguer F, Perez del Pulgar S, Gallart L, Lopez-Bermejo A, Kowalska I, Manco M, Cardona F, Garcia-Gil MM, Mingrone G, Richart C, Ricart W, Zorzano A. Protection from inflammatory disease in insulin resistance: The role of mannan-binding lectin. Diabetologia (2006) 49: 2402
- Seyfert-Margolis V, Gisler TD, Asare AL, Wang RS, Dosch HM, Brooks-Worrell B, Eisenbarth GS, Palmer JP, Greenbaum CJ, Gitelman SE, Nepom GT, Bluestone JA, Herold KC. Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes - Results of a blinded controlled study. Diabetes (2006) 55: 2588
- Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract (2006) 73: 284
- Tsutsumi Y, Jie X, Ihara K, Nomura A, Kanemitsu S, Takada H, Hara T. Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with type 1 diabetes. Diabet Med (2006) 23: 1145
- 6. Obesity
- Bakker AHF, Nijhuis J, Buurman WA, Van Dielen FMH, Greve JWM. Low number of omental preadipocytes with high leptin and low adiponectin secretion is associated with high fasting plasma glucose levels in obese subjects. Diabetes Obes Metab (2006) 8: 585
- Borodulin K, Tuomilehto J, Peltonen M, Lakka TA, Sundvall J, Jousilahti P. Association of leisure time physical activity and abdominal obesity with fasting serum insulin and 2-h postchallenge plasma glucose levels. Diabet Med (2006) 23: 1025
- Farooqi IS, Drop S, Clements A, Keogh JM, Biernacka J, Lowenbein S, Challis BG, O'Rahilly S. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes (2006) 55: 2549
- Kahn SE, Zinman B, Haffner SM, O'Neill MC, Kravitz BG, Yu DH, Freed MI, Herman WH, Holman RR, Jones NP, Lachin JM, Viberti GC. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes (2006) 55: 2357
- Katsuki A, Suematsu M, Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y, Sumida Y. Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract (2006) 73: 310
- Mari A, Manco M, Guidone C, Nanni G, Castagneto M, Mingrone G, Ferrannini E. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: Role of insulin sensitivity and beta cell function. Diabetologia (2006) 49: 2136
- Retnakaran R, Hanley AJG, Connelly PW, Harris SB, Zinman B. Elevated C-reactive protein in Native Canadian children: An ominous early complication of childhood obesity. Diabetes Obes Metab (2006) 8: 483
- Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: A potential mechanism for cardiovascular and metabolic risk. Diabetes (2006) 55: 2579
- 7. Prediction and Prevention
- Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, Yipintsoi T, Rajatanavin R. A risk score for predicting incident diabetes in the Thai population. Diabetes Care (2006) 29: 1872
- Bochenski J, Placha G, Wanic K, Malecki M, Sieradzki J, Warram JH, Krolewski AS. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes (2006) 55: 2626
- Cockram CS, Van Binh T, Galea G. Diabetes prevention and control in Viet Nam: A demonstration project in two provinces. Pract Diabetes Int (2006) 23: 361
10.1002/pdi.1011 Google Scholar
- Fumeron F, Tichet J, Pean F, Marre M, Driss F, Grandchamp B, Balkau B. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: The data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care (2006) 29: 2090
- Gunathilake W, Kulasinghe R, Siriwardana A, Hettiarchchi K, Thomson GA, Fernando DJS. Engaging the media in diabetes prevention in Sri Lanka. Pract Diabetes Int (2006) 23: 335
10.1002/pdi.1000 Google Scholar
- Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, Hoskin M, Kriska AM, Mayer-Davis EJ, Pi-Sunyer X, Regensteiner J, Venditti B, Wylie-Rosett J. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care (2006) 29: 2102
- Herder C, Peltonen M, Koenig W, Kraft I, Muller-Scholze S, Martin S, Lakka T, Ilanne-Parikka P, Eriksson JG, Hamalainen H, Keinanen-Kiukaanniemi S, Valle TT, Uusitupa M, Lindstrom J, Kolb H, Tuomilehto J. Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: Results from the Finnish Diabetes Prevention Study. Diabetes (2006) 55: 2340
- Hosseinpanah F, Rambod M, Ghaffari HRR, Azizi F. Predicting isolated postchallenge hyperglycaemia: A new approach: Tehran Lipid and Glucose Study (TLGS). Diabet Med (2006) 23: 982
- Narayan KMV, Saaddine JB, Boyle JP, Thompson TJ, Geiss LS. Impact of recent increase in incidence on future diabetes burden: US, 2005-2050. Diabetes Care (2006) 29: 2114
- Nishtar S, Shera S. Diabetes prevention and control as a part of an integrated non-communicable disease strategy: The Pakistan approach. Pract Diabetes Int (2006) 23: 332
10.1002/pdi.999 Google Scholar
- Park YW, Chang Y, Sung KC, Ryu S, Sung E, Kim WS. The sequential changes in the fasting plasma glucose levels within normoglycemic range predict type 2 diabetes in healthy, young men. Diabetes Res Clin Pract (2006) 73: 329
- Schulze MB, Bergmann MM, Heidemann C, Hoffmann K, Schienkiewitz A, Boeing H. Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study. Diabetes Care (2006) 29: 1921
- Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, Smith K, Johnson MK, Kitabchi A, Crandall J. Adherence to preventive medications - Predictors and outcomes in the Diabetes Prevention Program. Diabetes Care (2006) 29: 1997
- Zinman B, Harris SB, Gerstein HC, Young TK, Raboud JM, Neuman J, Hanley AJG. Preventing type 2 diabetes using combination therapy: Design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial. Diabetes Obes Metab (2006) 8: 531
- 8. Intervention: b) Care
- Ackermann RT, Stevens M, Thompson TJ, Brown AF, Selby JV, Narayan KMV, Safford MM. Is the number of documented diabetes process-of-care indicators associated with cardiometabolic risk factor levels, patient satisfaction, or self-rated quality of diabetes care? The Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2006) 29: 2108
- Bakker K, Abbas ZG, Pendsey S. Step by step, improving diabetic foot care in the developing world. A pilot study for India, Bangladesh, Sri Lanka and Tanzania. Pract Diabetes Int (2006) 23: 365
10.1002/pdi.1012 Google Scholar
- Colagiuri R. Building capacity to reduce diabetes complications in the Pacific: The Vanuatu experience so far. Pract Diabetes Int (2006) 23: 343
10.1002/pdi.1006 Google Scholar
- Corpeleijn E, Feskens EJM, Jansen EHJM, Mensink M, Saris WHM, De Bruin TWA, Blaak EE. Improvements in glucose tolerance and insulin sensitivity after lifestyle intervention are related to changes in serum fatty acid profile and desaturase activities: The SLIM study. Diabetologia (2006) 49: 2392
- Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, Covington MT, Peters JR. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia (2006) 49: 2272
- Davis WA, Bruce DG, Davis TME. Is self-monitoring of blood glucose appropriate for all type 2 diabetic patients? The Fremantle Diabetes Study. Diabetes Care (2006) 29: 1764
- Deakin TA, Cade JE, Williams R, Greenwood DC. Structured patient education: The diabetes X-PERT Programme makes a difference. Diabet Med (2006) 23: 944
- Dissanayake A, Idampitiya CA, Amarasinghe A, Thomson GA, Fernando DJS. Capacity building through research and educational collaboration: A report of a UK-Sri Lanka collaboration. Pract Diabetes Int (2006) 23: 350
10.1002/pdi.1008 Google Scholar
- Geddes J, McGeough E, Frier BM. Young adults with type 1 diabetes in tertiary education: Do students receive adequate specialist care?. Diabet Med (2006) 23: 1155
- Guthreau C, Castaneda A, Alen MC. Training people to live healthier lives and teach others to do the same. Pract Diabetes Int (2006) 23: 356
10.1002/pdi.1010 Google Scholar
- Heldgaard PE, Griffin SJ. Routinely collected general practice data aids identification of people with hyperglycaemia and metabolic syndrome. Diabet Med (2006) 23: 996
- Jacob AN, Adams-Huet B, Raskin P. The visceral and subcutaneous fat changes in type 1 diabetes: A pilot study. Diabetes Obes Metab (2006) 8: 524
- Jeffcoate WJ, Chipchase SY, Ince P, Game FL. Assessing the outcome of the management of diabetic foot ulcers using ulcer-related and person-related measures. Diabetes Care (2006) 29: 1784
- Johnson SL, Tierney EF, Onyemere KU, Tseng CW, Safford MM, Karter AJ, Ferrara A, Duru OK, Brown AF, Narayan KMV, Thompson TJ, Herman WH. Who is tested for diabetic kidney disease and who initiates treatment - The Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care (2006) 29: 1733
- Kirkman MS, Brizendine E, Shankar RR, Baron A, Shankar S, McGill J, Shen CY. Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: The Early Diabetes Intervention Program. Diabetes Care (2006) 29: 2095
- Lawton J, Ahmad N, Hanna L, Douglas M, Hallowell N. Diabetes service provision: A qualitative study of the experiences and views of Pakistani and Indian patients with type 2 diabetes. Diabet Med (2006) 23: 1003
- Looijmans-Van den Akker I, Verheij TJM, Buskens E, Nichol KL, Rutten GEHM, Hak E. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care (2006) 29: 1771
- Middlebrooke AR, Elston LM, MacLeod KM, Mawson DM, Ball CI, Shore AC, Tooke JE. Six months of aerobic exercise does not improve microvascular function in type 2 diabetes mellitus. Diabetologia (2006) 49: 2263
- Montori VM, Grace Y, Alonso-Coello P, Bhagra S. Systematic evaluation of the quality of randomized controlled trials in diabetes. Diabetes Care (2006) 29: 1833
- Obara T, Ohkubo T, Kikuya M, Asayama K, Metoki H, Inoue R, Oikawa T, Murai K, Komai R, Horikawa T, Hashimoto J, Totsune K, Imai Y. The current status of home and office blood pressure control among hypertensive patients with diabetes mellitus: The Japan Home Versus Office Blood Pressure Measurement Evaluation (J-HOME) study. Diabetes Res Clin Pract (2006) 73: 276
- Orr R, Tsang T, Lam P, Comino E, Singh MF. Mobility impairment in type 2 diabetes - Association with muscle power and effect of Tai Chi intervention. Diabetes Care (2006) 29: 2120
- Ramaiya K. Setting up diabetes clinics in Tanzania. Pract Diabetes Int (2006) 23: 339
10.1002/pdi.1001 Google Scholar
- Schutt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes (2006) 114: 384
- Subramaniam S. Curing curable blindness. Pract Diabetes Int (2006) 23: 341
10.1002/pdi.1003 Google Scholar
- Tomlin AM, Tilyard MW, Dovey SM, Dawson AG. Hospital admissions in diabetic and non-diabetic patients: A case-control study. Diabetes Res Clin Pract (2006) 73: 260
- Trento M, Tomelini M, Lattanzio R, Brancato R, Coggiola A, Benecchi R, Soccianti L, Insacco C, Bandello F, Montanaro M, Cavallo F, Porta M. Perception of, and anxiety levels induced by, laser treatment in patients with sight-threatening diabetic retinopathy. A multicentre study. Diabet Med (2006) 23: 1106
- Vainilovich Y, Danilova L, Zabarovskaya Z. Improving the diabetes care in Belarus. Pract Diabetes Int (2006) 23: 370
10.1002/pdi.1013 Google Scholar
- c) Drug Therapy
- Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GEO, Gustafson TA. Halofenate is a selective peroxisome proliferator-activated receptor γ modulator with antidiabetic activity. Diabetes (2006) 55: 2523
- Alvarez-Castro P, Isidro ML, Garcia-Buela J, Dieguez C, Casanueva FF, Cordido F. Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients. Diabetes Obes Metab (2006) 8: 555
- Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis: Thiazolidinedione treatment reverses these defects. Diabetes (2006) 55: 2277
- Barnett AH, Dreyer M, Lange P, Serdarevic-Pehar M. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin. Diabetes Care (2006) 29: 1818
- Clausen WHO, De Gaetano A, Volund A. Within-patient variation of the pharmacokinetics of subcutaneously injected biphasic insulin aspart as assessed by compartmental modelling. Diabetologia (2006) 49: 2030
- An D, Kewalramani G, Chan JKY, Qi D, Ghosh S, Pulinilkunnil T, Abrahani A, Innis SM, Rodrigues B. Metformin influences cardiomyocyte cell death by pathways that are dependent and independent of caspase-3. Diabetologia (2006) 49: 2174
- De Block C, Manuel-y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: Assessment by continuous glucose monitoring. Diabetes Care (2006) 29: 1750
- De Boer H, Keizers R, Jansen M, Verschoor L, Ruineman-Koerts J. Glycaemic control without weight gain in insulin requiring type 2 diabetes: 1-year results of the GAME regimen. Diabetes Obes Metab (2006) 8: 517
- De Fine Olivarius N, Andreasen AH, Siersma V, Richelsen B, Beck-Nielsen H. Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus. Diabetologia (2006) 49: 2058
- Hausmann M, Dellweg S, Osborn C, Heinemann L, Buchwald A, Rosskamp R, Genova P, Heise T. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: A controlled proof-of-concept study. Diabetes Obes Metab (2006) 8: 574
- Hompesch M, Troupin B, Heise T, Elbroend B, Endahl L, Haahr H, Heinemann L. Time-action profile of insulin detemir and NPH insulin in patients with type 2 diabetes from different ethnic groups. Diabetes Obes Metab (2006) 8: 568
- Kautzky-Willer A, Tura A, Winzer C, Wagner OF, Ludvik B, Hanusch-Enserer U, Prager R, Pacini G. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes Obes Metab (2006) 8: 561
- Khan ASA, McLoughney CR, Ahmed AB. The effect of metformin on blood glucose control in overweight patients with type 1 diabetes. Diabet Med (2006) 23: 1079
- Kim W, Khil LY, Clark R, Bok SH, Kim EE, Lee S, Jun HS, Yoon JW. Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4. Diabetologia (2006) 49: 2437
- Lee YS, Kim WS, Kim KH, Yoon MJ, Cho HJ, Shen Y, Ye JM, Lee CH, Oh WK, Kim CT, Hohnen-Behrens C, Gosby A, Kraegen EW, James DE, Kim JB. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes (2006) 55: 2256
- Marchetti V, Menghini R, Rizza S, Vivanti A, Feccia T, Lauro D, Fukamizu A, Lauro R, Federici M. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes (2006) 55: 2231
- Martin J, Wang ZQ, Zhang XH, Wachtel D, Volaufova J, Matthews DE, Cefalu WT. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes. Diabetes Care (2006) 29: 1826
- Matikainen N, Manttari S, Schweizer A, Ulvestad A, Mills D, Dunning BE, Foley JE, Taskinen MR. Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes. Diabetologia (2006) 49: 2049
- Melander A, Folino-Gallo P, Walley T, Schwabe U, Groop PH, Klaukka T, Vallano A, Laporte JR, Gallego MR, Schiappa M, Roder M, Kampmann JP, De Swaef A, Aberg M, Mansson NO, Lindblad U. Utilisation of antihyperglycaemic drugs in ten European countries: Different developments and different levels. Diabetologia (2006) 49: 2024
- Nishiu J, Ito M, Ishida Y, Kakutani M, Shibata T, Matsushita M, Shindo M. JTP-426467 acts as a selective antagonist for peroxisome proliferator-activated receptor γ in vitro and in vivo. Diabetes Obes Metab (2006) 8: 508
- Papa G, Fedele V, Rizzo MR, Fioravanti M, Leotta C, Solerte SB, Purrello F, Paolisso G. Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial. Diabetes Care (2006) 29: 1918
- Pfutzner J, Forst T, Butzer R, Forst S, Weber MM, Pfutzner AH, Pfutzner A. Performance of the continuous glucose monitoring system (CGMS) during development of ketosis in patients on insulin pump therapy. Diabet Med (2006) 23: 1124
- Rave K, Klein O, Frick AD, Becker RHA. Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes. Diabetes Care (2006) 29: 1812
- Schiekofer S, Galasso G, Andrassy M, Aprahamian T, Schneider J, Rocnik E. Glucose control with insulin results in reduction of NF-κB-binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes. Diabetes Obes Metab (2006) 8: 473
- Shah BR, Hux JE, Laupacis A, Zinman B, Booth GL. Use of vascular risk-modifying medications for diabetic patients differs between physician specialities. Diabet Med (2006) 23: 1117
- Stephan D, Winkler M, Kuhner P, Russ U, Quast U. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K-ATP channels. Diabetologia (2006) 49: 2039
- Stewart MW, Cirkel DT, Furuseth K, Donaldson J, Biswas N, Starkie MG, Phenekos C, Hamann A. Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled type 2 diabetes. Diabet Med (2006) 23: 1069
- Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Gotting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes. Diabetes Care (2006) 29: 2064
- Tan GD, Olivecrona G, Vidal H, Frayn KN, Karpe F. Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: Role of adipose tissue and skeletal muscle in response to rosiglitazone. Diabetologia (2006) 49: 2412
- d)Economics
- Icks A, Haastert B, Giani G, Rathmann W. Incremental prescription and drug costs during the years preceding diabetes diagnosis in primary care practices in Germany. Exp Clin Endocrinol Diabetes (2006) 114: 348
- e) Gene therapy
- Barbu AR, Bodin B, Welsh M, Jansson L, Welsh N. A perfusion protocol for highly efficient transduction of intact pancreatic islets of Langerhans. Diabetologia (2006) 49: 2388
- f) Nursing
- Sampson MJ, Crowle T, Dhatariya K, Dozio N, Greenwood RH, Heyburn PJ, Jones C, Temple RC, Walden E. Trends in bed occupancy for inpatients with diabetes before and after the introduction of a diabetes inpatient specialist nurse service. Diabet Med (2006) 23: 1008
- g) Nutrition
- Barnard ND, Cohen J, Jenkins DJA, Turner-McGrievy G, Gloede L, Jaster B, Seidl K, Green AA, Talpers S. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes. Diabetes Care (2006) 29: 1777
- Marfella R, Cacciapuoti F, Siniscalchi M, Sasso FC, Marchese F, Cinone F, Musacchio E, Marfella MA, Ruggiero L, Chiorazzo G, Liberti D, Chiorazzo G, Nicoletti GF, Saron C, D'Andrea F, Ammendola C, Verza M, Coppola L. Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with type 2 diabetes mellitus. Diabet Med (2006) 23: 974
- Morse SA, Ciechanowski PS, Katon WJ, Hirsch IB. Isn't this just bedtime snacking? The potential adverse effects of night-eating symptoms on treatment adherence and outcomes with diabetes. Diabetes Care (2006) 29: 1800
- Roberts CK, Won D, Pruthi S, Lin SS, Barnard RJ. Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men. Diabetes Res Clin Pract (2006) 73: 249
- h) Surgery
- Breeman A, De Boer MJ, Bertrand ME, Wijns W, Ottervanger JP, Boersma E, Hoeks S, Lenzen M, Sechtem U, Legrand V. Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease. Diabetes Care (2006) 29: 2003
- i) Transplantation
- Barbe-Tuana FM, Klein D, Ichii H, Berman DM, Coffey L, Kenyon NS, Ricordi C, Pastori RL. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes (2006) 55: 2437
- Bussiere CT, Lakey JRT, Shapiro AMJ, Korbutt GS. The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells. Diabetologia (2006) 49: 2341
- Evgenov NV, Medarova Z, Pratt J, Pantazopoulos P, Leyting S, Bonner-Weir S, Moore A. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes (2006) 55: 2419
- Meier JJ, Hong-McAtee I, Galasso R, Veldhuis JD, Moran A, Hering BJ, Butler PC. Intrahepatic transplanted islets in humans secrete insulin in a coordinate pulsatile manner directly into the liver. Diabetes (2006) 55: 2324
- Sassa M, Fukuda K, Fujimoto S, Toyoda K, Fujita Y, Matsumoto S, Okitsu T, Iwanaga Y, Noguchi H, Nagata H, Yonekawa Y, Ohara T, Okamoto M, Tanaka K, Seino Y, Inagaki N, Yamada Y. A single transplantation of the islets can produce glycemic stability and reduction of basal insulin requirement. Diabetes Res Clin Pract (2006) 73: 235
- Zhang N, Su DM, Qu S, Tse T, Bottino R, Balamurugan AN, Xu J, Bromberg JS, Dong HH. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function. Diabetes (2006) 55: 2429
- 9. Pathology and Complications: a) General
- Edge JA, Jakes RW, Roy Y, Hawkins M, Winter D, Ford-Adams ME, Murphy NP, Bergomi A, Widmer B, Dunger DB. The UK case-control study of cerebral oedema complicating diabetic ketoacidosis in children. Diabetologia (2006) 49: 2002
- Yu Y, Thorpe SR, Jenkins AJ, Shaw JN, Sochaski MA, Mcgee D, Aston CE, Orchard TJ, Silvers N, Peng YG, McKnight JA, Baynes JW, Lyons TJ. Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes. Diabetologia (2006) 49: 2488
- b) Cardiovascular
- Allport L, Baird T, Butcher K, MacGregor L, Prosser J, Colman P, Davis S. Frequency and temporal profile of poststroke hyperglycemia using continuous glucose monitoring. Diabetes Care (2006) 29: 1839
- Hu G, Jousilahti P, Sarti C, Antikainen R, Tuomilehto J. The effect of diabetes and stroke at baseline and during follow-up on stroke mortality. Diabetologia (2006) 49: 2309
- Junga K, Merlo J, Gullberg B, Bog-Hansen E, Rastam L, Lindblad U. Residual risk for acute stroke in patients with type 2 diabetes and hypertension in primary care: Skaraborg Hypertension and Diabetes Project. Diabetes Obes Metab (2006) 8: 492
- Lyons TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virela M, Garvey WT. Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Associations with carotid intima-media thickness. Diabet Med (2006) 23: 955
- Marso SP, Safley DM, House JA, Tessendorf T, Redi KJ, Spertus JA. Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population. Diabetes Care (2006) 29: 1931
- Mohler ER, Lech G, Supple GE, Wang H, Chance B. Impaired exercise-induced blood volume in type 2 diabetes with or without peripheral arterial disease measured by continuous-wave near-infrared spectroscopy. Diabetes Care (2006) 29: 1856
- Morgan CL, McEwan P, Morrissey M, Peters JR, Poole C, Currie CJ. Characterization and comparison of the health-related utility in people with diabetes with various single and multiple vascular complications. Diabet Med (2006) 23: 1100
- Morita S, Kasayama S, Otsuki M, Asanuma N, Saito H, Mukai M, Koga M. Atherosclerotic risk factors in Japanese subjects with isolated impaired fasting glucose and those with isolated impaired glucose tolerance according to 1997 and 2003 American Diabetes Association criteria. Diabetes Care (2006) 29: 2123
- Oyama T, Miyasita Y, Watanabe H, Shirai K. The role of polyol pathway in high glucose-induced endothelial cell damages. Diabetes Res Clin Pract (2006) 73: 227
- Papazafiropoulou A, Perrea D, Tentolouris N, Katsilambros N, Moyssakis I. The potential effect of some newer risk factors for atherosclerosis on aortic distensibility in subjects with and without type 2 diabetes. Diabetes Care (2006) 29: 1926
- Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, Imperatore G, Williams DE, Bell RA, Wadwa RP, Palla SL, Liu LL, Kershnar A, Daniels SR, Linder B. Prevalence of cardiovascular disease risk factors in US children and adolescents with diabetes: The SEARCH for Diabetes in Youth study. Diabetes Care (2006) 29: 1891
- Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes. Diabetes (2006) 55: 2245
- Smith NL, Lumley T, Barzilay JI, Enquobahrie D, Kronmal R, Psaty BM. New-onset diabetes and risk of all-cause and cardiovascular mortality - The cardiovascular health study. Diabetes Care (2006) 29: 2012
- Tillin T, Forouhi NG, Mckeigue PM, Chaturvedi N. The role of diabetes and components of the metabolic syndrome in stroke and coronary heart disease mortality in UK white and African-Caribbean populations. Diabetes Care (2006) 29: 2127
- Toledo FGS, Sniderman AD, Kelley DE. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Diabetes Care (2006) 29: 1845
- Wallander M, Brismar K, Ohrvik J, Ryden L, Norhammar A. Insulin-like growth factor I: A predictor of long-term glucose abnormalities in patients with acute myocardial infarction. Diabetologia (2006) 49: 2247
- Yoshimura T, Suzuki E, Egawa K, Nishio Y, Maegawa H, Morikawa S, Inubushi T, Hisatomi A, Fujimoto K, Kashiwagi A. Low blood flow estimates in lower-leg arteries predict cardiovascular events in Japanese patients with type 2 diabetes with normal ankle-brachial indexes. Diabetes Care (2006) 29: 1884
- Zandbergen AAM, Sijbrands EJ, Lamberts SW, Bootsma AH. Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease. Diabetes Care (2006) 29: 1851
- Zgibor JC, Piatt GA, Ruppert K, Orchard TJ, Roberts MS. Deficiencies of cardiovascular risk prediction models for type 1 diabetes. Diabetes Care (2006) 29: 1860
- c) Eye disease
- Ben-Mahmud BM, Chan WH, Abdulahad RM, Datti A, Orlacchio A, Kohner EM, Chibber R. Clinical validation of a link between TNF-α and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy. Diabetologia (2006) 49: 2185
- Hernandez C, Catalan R, Fonolloa A, Miralles A, Garcia-Ramirez M, Garcia-Arumi J, Higuera M, Simo R. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care (2006) 29: 2028
- Ogata N, Nomura S, Akira S, Imaizumi M, Arichi M, Matsumura M. Elevation, of monocyte-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract (2006) 73: 241
- Polska E, Kolodjaschna J, Berisha F, Malec MM, Simader C, Bayerle-Eder M, Roden M, Schmetterer L. C-peptide does not affect ocular blood flow in patients with type 1 diabetes. Diabetes Care (2006) 29: 2034
- Rema M, Srivastava BK, Anitha B, Deepa R, Mohan V. Association of serum lipids with diabetic retinopathy in urban South Indians - The Chennai Urban Rural Epidemiology Study (CURES) Eye Study—2. Diabet Med (2006) 23: 1029
- Robertson N, Burden ML, Burden AC. Psychological morbidity and problems of daily living in people with visual loss and diabetes: Do they differ from people without diabetes?. Diabet Med (2006) 23: 1110
- Skrivarhaug T, Fosmark DS, Stene LC, Bangstad HJ, Sandvik L, Hanssen KF, Joner G. Low cumulative incidence of proliferative retinopathy in childhood-onset type 1 diabetes: A 24-year follow-up study. Diabetologia (2006) 49: 2281
- Tapp RJ, Zimmet PZ, Harper CA, McCarty DJ, Chitson P, Tonkin AM, Soderberg S, Taylor HR, Alberti KGMM, Tuomilehto J, Shaw JE. Six year incidence and progression of diabetic retinopathy: Results from the Mauritius diabetes complication study. Diabetes Res Clin Pract (2006) 73: 298
- Tapp RJ, Zimmet PZ, Harper CA, De Courten MP, McCarty DJ, Balkau B, Taylor HR, Welborn TA, Shaw JE. Diagnostic thresholds for diabetes: The association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract (2006) 73: 315
- Wessels AM, Simsek S, Remijnse PL, Veltman DJ, Biessels GJ, Barkhof F, Scheltens P, Snoek FJ, Heine RJ, Rombouts SARB. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia (2006) 49: 2474
- d) Gestational and fetal
- Carr DB, Utzschneider KM, Hull RL, Tong J, Wallace TM, Kodama K, Shofer JB, Heckbert SR, Boyko EJ, Fujimoto WY, Kahn SE. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care (2006) 29: 2078
- Kieffer EC, Sinco B, Kim C. Health behaviors among women of reproductive age with and without a history of gestational diabetes mellitus. Diabetes Care (2006) 29: 1788
- Lo JC, Yang JR, Feigenbaum SL, Crites YM, Escobar GJ, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome - A population-based study. Diabetes Care (2006) 29: 1915
- Silva JK, Kaholokula JK, Ratner R, Mau M. Ethnic differences in perinatal outcome of gestational diabetes mellitus. Diabetes Care (2006) 29: 2058
- Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care (2006) 29: 1744
- e) Neurological
- Coppini DV, Spruce MC, Thomas P, Masding MG. Established diabetic neuropathy seems irreversible despite improvements in metabolic and vascular risk markers—A retrospective case-control study in a hospital patient cohort. Diabet Med (2006) 23: 1016
- Daousi C, Benbow SJ, Woodward A, MacFarlane IA. The natural history of chronic painful peripheral neuropathy in a community diabetes population. Diabet Med (2006) 23: 1021
- Marthol H, Brown CM, Zikeli U, Ziegler D, Dimitrov N, Baltadzhieva R, Hilz MJ. Altered cerebral regulation in type 2 diabetic patients with cardiac autonomic neuropathy. Diabetologia (2006) 49: 2481
- Munshi M, Grande L, Hayes M, Ayres D, Suhl E, Capelson R, Lin S, Milberg W, Weinger K. Cognitive dysfunction is associated with poor diabetes control in older adults. Diabetes Care (2006) 29: 1794
- Ohlsson B, Melander O, Thorsson O, Olsson R, Ekberg O, Sundkvist G. Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia (2006) 49: 2010
- Van den Berg E, De Craen AJM, Biessels GJ, Gussekloo J, Westendorp RGJ. The impact of diabetes mellitus on cognitive decline in the oldest of the old: A prospective population-based study. Diabetologia (2006) 49: 2015
- f) Podiatrical
- Gadepalli R, Dhawan B, Sreenivas V, Kapil A, Ammini AC, Chaudhry R. A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital. Diabetes Care (2006) 29: 1727
- g) Renal
- Baskar V, Venugopal H, Holland MR, Singh BM. Clinical utility of estimated glomerular filtration rates in predicting renal risk in a district diabetes population. Diabet Med (2006) 23: 1057
- Stone ML, Craig ME, Chan AK, Lee JW, Verge CF, Donaghue KC. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: A longitudinal study. Diabetes Care (2006) 29: 2072
- Yang XL, So WY, Kong APS, Clarke P, Ho CS, Lam CWK, Ng MHL, Lyu RR, Yin DD, Chow CC, Cockram CS, Tong PC, Chan JCN. End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry. Diabetologia (2006) 49: 2299
- Zerbini G, Bonfanti R, Meschi F, Bognetti E, Paesano PL, Gianolli L, Querques M, Maestroni A, Calori G, Del Maschio A, Fazio F, Luzi L, Chiumello G. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes (2006) 55: 2620
- 10. Endocrinology & Metabolism
- Bell JA, Volpi E, Fujita S, Cadenas JG, Rasmussen BB. Dysregulation of muscle fatty acid metabolism in type 2 diabetes is independent of malonyl-CoA. Diabetologia (2006) 49: 2144
- Bloch-Damti A, Potashnik R, Gual P, Le Marchand-Brustel Y, Tanti JF, Rudich A, Bashan N. Differential effects of IRS1 phosphorylated on Ser307 or Ser632 in the induction of insulin resistance by oxidative stress. Diabetologia (2006) 49: 2463
- Costes S, Broca C, Bertrand G, Lajoix AD, Bataille D, Bockaert J, Dalle S. ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: A key role in glucose-mediated pancreatic beta-cell survival. Diabetes (2006) 55: 2220
- Draznin B. Molecular mechanisms of insulin resistance: Serine phosphorylation of insulin receptor substrate-1 and increased expression of p85α: The two sides of a coin. Diabetes (2006) 55: 2392
- Estella E, McKenzie MD, Catterall T, Sutton VR, Bird PI, Trapani JA, Kay TW, Thomas HE. Granzyme B-mediated death of pancreatic beta-cells requires the proapoptotic BH3-only molecule bid. Diabetes (2006) 55: 2212
- Hauge-Evans AC, Richardson CC, Milne HM, Christie MR, Persaud SJ, Jones PM. A role for kisspeptin in islet function. Diabetologia (2006) 49: 2131
- Hoeks J, Hesselink MKC, Russell AP, Mensink M, Saris WHM, Mensink RP, Schrauwen P. Peroxisome proliferator-activated receptor-γ coactivator-1 and insulin resistance: Acute effect of fatty acids. Diabetologia (2006) 49: 2419
- Johnson NA, Stannard SR, Rowlands DS, Chapman PG, Thompson CH, Sachinwalla T, Thompson MW. Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated. Diabet Med (2006) 23: 1061
- Jones JG, Fagulha A, Barosa C, Bastos M, Barros L, Baptista C, Caldeira MM, Carvalheiro M. Noninvasive analysis of hepatic glycogen kinetics before and after breakfast with deuterated water and acetaminophen. Diabetes (2006) 55: 2294
- Kharroubi I, Lee CH, Hekerman P, Darville MI, Evans RM, Eizirik DL, Cnop M. BCL-6: A possible missing link for anti-inflammatory PPAR-δ signalling in pancreatic beta cells. Diabetologia (2006) 49: 2350
- Kim YI, Lee FN, Choi WS, Lee S, Youn JH. Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes (2006) 55: 2311
- Liuwantara D, Elliot M, Smith MW, Yam AO, Walters SN, Marino E, McShea A, Grey ST. Nuclear factor-KB regulates beta-cell death - A critical role for A20 in beta-cell production. Diabetes (2006) 55: 2491
- Lopez-Bermejo A, Khosravi J, Fernandez-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gill MM, Rosenfeld RG, Ricart W. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes (2006) 55: 2333
- Maedler K, Schumann DM, Schulthess F, Oberholzer J, Bosco D, Berney T, Donath MY. Aging correlates with decreased beta-cell proliferative capacity and enhanced sensitivity to apoptosis: A potential role for Fas and pancreatic duodenal homeobox-1. Diabetes (2006) 55: 2455
- Marzban L, Rhodes CJ, Steiner DF, Haataja L, Halban PA, Verchere CB. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes (2006) 55: 2192
- Meyer C, Szoke E, Pimenta W, Mitrakou A, Woerle HJ, Gerich J, Van Haeften T. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care (2006) 29: 1909
- Palumbo MO, Levi D, Chentoufi AA, Polychronakos C. Isolation and characterization of proinsulin-producing medullary thymic epithelial cell clones. Diabetes (2006) 55: 2595
- Quesada I, Todorova MG, Alonso-Magdalena P, Beltra M, Carneiro EM, Martin F, Nadal A, Soria B. Glucose induces opposite intracellular Ca2+ concentration oscillatory patterns in identified alpha-and beta-cells within intact human islets of Langerhans. Diabetes (2006) 55: 2463
- Salehi A, Vieira E, Gylfe E. Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes (2006) 55: 2318
- Saukkonen T, Shojaee-Moradie F, Williams RM, Amin R, Yuen KC, Watts A, Acerini CL, Umpleby AM, Dunger DB. Effects of recombinant human IGF-I/IGF-binding protein-3 complex on glucose and glycerol metabolism in type 1 diabetes. Diabetes (2006) 55: 2365
- Schmelzle K, Kane S, Gridley S, Lienhard GE, White FM. Temporal dynamics of tyrosine phosphorylation in insulin signaling. Diabetes (2006) 55: 2171
- Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM, Hoogeveen RC, Heiss G. Leptin and incident type 2 diabetes: Risk or protection?. Diabetologia (2006) 49: 2086
- Solini A, Santini E, Nannipieri M, Ferrannini E. High glucose and homocysteine synergistically affect the metalloproteinases-tissue inhibitors of metalloproteinases pattern, but not TGFB expression, in human fibroblasts. Diabetologia (2006) 49: 2499
- Tarasov AI, Girard CAJ, Ashcroft FM. ATP sensitivity of the ATP-sensitive K+ channel in intact and permeabilized pancreatic beta-cells. Diabetes (2006) 55: 2446
- Tchkonia T, Giorgadze N, Pirtskhalava T, Thomou T, DePonte M, Koo A, Forse RA, Chinnappan D, Martin-Ruiz C, Von Zglinicki T, Kirkland JL. Fat depot-specific characteristics are retained in strains derived from single human preadipocytes. Diabetes (2006) 55: 2571
- Wang XL, Zhang L, Youker K, Zhang MX, Wang J, LeMaire SA, Coselli JS, Shen YH. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes (2006) 55: 2301
- Wente W, Efanov AM, Brenner M, Kharitonenkov A, Koster A, Sandusky GE, Sewing S, Treinies I, Zitzer H, Gromada J. Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signalling pathways. Diabetes (2006) 55: 2470
- Yoon MJ, Lee GY, Chung JJ, Ahn YH, Hong SH, Kim JB. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor α. Diabetes (2006) 55: 2562
- 11. Experimental Studies
- Brugman S, Klatter FA, Visser JTJ, Wildeboer-Veloo ACM, Harmsen HJM, Rozing J, Bos NA. Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?. Diabetologia (2006) 49: 2105
- Castellano JM, Navarro VM, Fernandez-Fernandez R, Roa J, Vigo E, Pineda R, Dieguez C, Aguilar E, Pinilla L, Tena-Sempere M. Expression of hypothalamic KiSS-1 system and rescue of defective gonadotropic responses by kisspeptin in streptozotocin-induced diabetic male rats. Diabetes (2006) 55: 2602
- Crescenzo R, Lionetti L, Mollica MP, Ferraro M, D'Andrea E, Mainieri D, Dulloo AG, Liverini G, Iossa S. Altered skeletal muscle subsarcolemmal mitochondrial compartment during catch-up fat after caloric restriction. Diabetes (2006) 55: 2286
- Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JRB, Girard J, Postic C. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes (2006) 55: 2159
- Dudek NL, Thomas HE, Mariana L, Sutherland RM, Allison J, Estella E, Angstetra E, Trapani JA, Santamaria P, Lew AM, Kay TWH. Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes (2006) 55: 2412
- Estrada-Smith D, Collins AR, Wang XP, Crockett C, Castellani L, Lusis AJ, Davis RC. Impact of chromosome 2 obesity loci on cardiovascular complications of insulin resistance in LDL receptor-deficient C57BL/6 mice. Diabetes (2006) 55: 2265
- Festuccia WT, Laplante M, Berthiaume M, Gelinas Y, Deshaies Y. PPARγ agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control. Diabetologia (2006) 49: 2427
- Flores MBS, Fernandes MFA, Ropelle ER, Faria MC, Ueno M, Velloso LA, Saad MJA, Carvalheira JBC. Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes (2006) 55: 2554
- Fujimoto Y, Torres TP, Donahue EP, Shiota M. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes (2006) 55: 2479
- Galea E, Feinstein DL, Lacombe P. Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice. Diabetologia (2006) 49: 2153
- Gohda T, Tanimoto M, Kaneko S, Shibata T, Funabiki K, Horikoshi S, Tomino Y. Minor gene effect of leptin receptor variant on the body weight in KK/Ta mice. Diabetes Obes Metab (2006) 8: 581
- Jeansson M, Granqvist AB, Nystrom JS, Haraldsson B. Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia (2006) 49: 2200
- Lagathu C, Yvan-Charvet L, Bastard JP, Maachi M, Quignard-Boulange A, Capeau J, Caron M. Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes. Diabetologia (2006) 49: 2162
- Li SL, Reddy MA, Cai QJ, Meng L, Yuan H, Lanting L, Natarajan R. Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes (2006) 55: 2611
- Makino H, Mukoyama M, Mori K, Suganami T, Kasahara M, Yahata K, Nagae T, Yokoi H, Sawai K, Ogawa Y, Suga S, Yoshimasa Y, Sugawara A, Tanaka I, Nakao K. Transgenic overexpression of brain natriuretic peptide prevents the progression of diabetic nephropathy in mice. Diabetologia (2006) 49: 2514
- Matveyenko AV, Veldhuis JD, Butler PC. Mechanisms of impaired fasting glucose and glucose intolerance induced by a ˜ 50% pancreatectomy. Diabetes (2006) 55: 2347
- Myint KM, Yamamoto Y, Doi T, Kato I, Harashima A, Yonekura H, Watanabe T, Shinohara H, Takeuchi M, Tsuneyama K, Hashimoto N, Asano M, Takasawa S, Okamoto H, Yamamoto H. RAGE control of diabetic nephropathy in a mouse model - Effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes (2006) 55: 2510
- Niklasson B, Samsioe A, Blixt M, Sandler S, Sjoholm A, Lagerquist E, Lernmark A, Klitz W. Prenatal viral exposure followed by adult stress produces glucose intolerance in a mouse model. Diabetologia (2006) 49: 2192
- Nolan CJ, Leahy JL, Delghingaro-Augusto V, Moibi J, Soni K, Peyot ML, Fortier M, Guay C, Lamontagne J, Barbeau A, Przybytkowski E, Joly E, Masiello P, Wang S, Mitchell GA, Prentki M. Beta cell compensation for insulin resistance in Zucker fatty rats: Increased lipolysis and fatty acid signalling. Diabetologia (2006) 49: 2120
- Obrosova IG, Drel VR, Kumagai AK, Szabo C, Pacher P, Stevens MJ. Early diabetes-induced biochemical changes in the retina: Comparison of rat and mouse models. Diabetologia (2006) 49: 2525
- Planas R, Alba A, Carrillo J, Puertas MC, Ampudia R, Pastor X, Okamoto H, Takasawa S, Gurr W, Pujol-Borrell R, Verdaguer J, Vives-Pi M. Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: Role of IFNβ. Diabetologia (2006) 49: 2379
- Proctor G, Jiang T, Iwahashi M, Wang ZW, Li JP, Levi M. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes (2006) 55: 2502
- Remedi MS, Rocheleau JV, Tong A, Patton BL, McDaniel ML, Piston DW, Koster JC, Nichols CG. Hyperinsulinism in mice with heterozygous loss of K-ATP channels. Diabetologia (2006) 49: 2368
- Sasase T, Ohta T, Ogawa N, Miyajima K, Ito M, Yamamoto H, Morinaga H, Matsushita M. Preventive effects of glycaemic control on ocular complications of Spontaneously Diabetic Torii rat. Diabetes Obes Metab (2006) 8: 501
- Taniguchi Y, Ooie T, Takahashi N, Shinohara T, Nakagawa M, Yonemochi H, Hara M, Yoshimatsu H, Saikawa T. Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat. Diabetes (2006) 55: 2371
- Todoric J, Loffler M, Huber J, Bilban M, Reimers M, Kadl A, Zeyda M, Waldhausl W, Stulnig TM. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia (2006) 49: 2109
- Ueno M, Carvalheira JBC, Oliveira RLGS, Velloso LA, Saad MJA. Circulating ghrelin concentrations are lowered by intracerebroventricular insulin. Diabetologia (2006) 49: 2449
- Wang P, Keijer J, Bunschoten A, Bouwman F, Renes J, Mariman E. Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: A role for transcriptional regulation of processing. Diabetologia (2006) 49: 2453
- Westermann D, Rutschow S, Van Linthout S, Linderer A, Bucker-Gartner C, Sobirey M, Riad A, Pauschinger M, Schultheiss HP, Tschope C. Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus. Diabetologia (2006) 49: 2507
- Yamamoto T, Yamato E, Taniguchi H, Shimoda M, Tashiro F, Hosoi M, Sato T, Fujii S, Miyazaki JI. Stimulation of cAMP signalling allows isolation of clonal pancreatic precursor cells from adult mouse pancreas. Diabetologia (2006) 49: 2359
- Yi XW, Maeda N. α-Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes (2006) 55: 2238
- Zang MW, Xu SQ, Maitland-Toolan KA, Zuccollo A, Hou XY, Jiang BB, Wierzbicki M, Verbeuren TJ, Cohen RA. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes (2006) 55: 2180
- 12. Diagnosis and Techniques
- Costa LA, Maraschin JF, Xavier de Castro JH, Gross JL, Friedman R. A simplified protocol to screen for distal polyneuropathy in type 2 diabetic patients. Diabetes Res Clin Pract (2006) 73: 292
- Karter AJ, Parker MM, Moffet HH, Spence MM, Chan J, Ettner SL, Selby JV. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care (2006) 29: 1757
- Muroi R, Yagyu H, Kobayashi H, Nagata M, Sato N, Ideno J, Fujita N, Ando A, Okada K, Takiyama Y, Nagasaka S, Miyajima H, Nakano I, Ishibashi S. Early onset insulin-dependent diabetes mellitus as an initial manifestation of aceruloplasminaemia. Diabet Med (2006) 23: 1136
- Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M. A simple way to estimate mean plasma glucose and to identify type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available. Diabet Med (2006) 23: 1151
- Perkins BA, Ngo M, Grewal J, Ng E, Bril V. Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care (2006) 29: 2023
- Peter R, Luzio SD, Dunseath G, Pauvaday V, Mustafa N, Owens DR. Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with type 2 diabetes. Diabet Med (2006) 23: 990
- Wentholt IM, Hoekstra JB, DeVries JH. A critical appraisal of the continuous glucose-error grid analysis. Diabetes Care (2006) 29: 1805